| Closed |
S0601 |
NON-HODGKINS: R-CHOP-V followed by VM maintenance therapy for MCL |
8/15/2006 |
6/1/2008 |
100% |
|
Published
|
| Closed |
SWOG-437 |
NSC-409962 ... 1, 3-bis(2-chloroethyl)-1-nitrosourea (BCNU) Phase II study ... Advanced Breast Cancer |
1/19/1970 |
|
53% |
|
|
| Closed |
S0629 |
Observational and Phase II WM w/ Trans. & Maint. for Symptomatic WM |
9/15/2008 |
|
0% |
|
|
| Closed |
S0120 |
Observational MGUS / Asymptomatic Myeloma and Plasma Proliferative Disorders |
6/1/2002 |
4/1/2011 |
97% |
|
Published
|
| Closed |
S1612 |
Older AML |
12/22/2017 |
|
5% |
|
|
| Closed |
S0341 |
OSI-774/PS 2/selected Stage IIIB or IV NSCLC |
9/15/2004 |
10/1/2005 |
100% |
|
Published
|
| Closed |
S9701 |
OVARIAN |
11/15/1997 |
12/1/2001 |
62% |
|
Published
|
| Closed |
S9912 |
OVARIAN |
10/1/2000 |
8/15/2005 |
100% |
|
Published
|
| Closed |
S0009 |
OVARIAN |
3/15/2001 |
2/1/2006 |
100% |
|
Published
|
| Closed |
S0211 |
Ovarian |
4/15/2002 |
1/1/2006 |
77% |
|
Published
|
| Closed |
S0200 |
OVARIAN |
8/15/2002 |
12/15/2004 |
6% |
|
Published
|
| Closed |
S0025 |
OVARIAN |
2/15/2003 |
8/15/2003 |
5% |
|
|
| Closed |
S9700 |
PANCREAS |
9/15/1997 |
6/19/2001 |
90% |
|
Published
|
| Closed |
S9924 |
PANCREAS |
6/1/2000 |
6/1/2001 |
97% |
|
Published
|
| Closed |
S0107 |
PANCREAS |
7/1/2001 |
6/1/2003 |
100% |
|
Published
|
| Closed |
S0727 |
Pancreas Ph I/II gemcitabine, erlotinib, IMC-A12 |
3/1/2008 |
9/1/2010 |
100% |
|
Published
|
| Closed |
S0205 |
PANCREATIC |
1/1/2004 |
4/1/2006 |
100% |
|
Published
|
| Closed |
S1107 |
Papillary Renal, ARQ 197 +/- Erlotinib, Ph II |
8/20/2012 |
5/29/2014 |
71% |
|
|
| Open |
S2001 |
Parallel Randomized Phase II Clinical Trial of Olaparib + Pembrolizumab vs. Olaparib as Maintenance Therapy in Two Cohorts of Metastatic Pancreatic Cancer Patients with DNA Damage Repair Defects |
12/4/2020 |
|
59% |
|
|
| Closed |
S0437 |
PCPT Long Term Follow Up |
9/1/2005 |
3/1/2009 |
53% |
|
|
